Eye Journal
South Asian diabetic macular oedema treated with ranibizumab (ADMOR)—real-life experience – (Eye 30, 133 (January 2016))
South Asian diabetic macular oedema treated with ranibizumab (ADMOR)—real-life experience Eye 30, 133 (January 2016). doi:10.1038/eye.2015.209 Authors: F Ghanchi & C A Hazel
Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study – (Eye 30, 139 (January 2016))
Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study Eye 30, 139 (January 2016). doi:10.1038/eye.2015.199 Authors: C Bruè, A Pazzaglia, C Mariotti, M Reibaldi & A Giovannini
Complement pathway biomarkers and age-related macular degeneration – (Eye 30, 1 (January 2016))
Complement pathway biomarkers and age-related macular degeneration Eye 30, 1 (January 2016). doi:10.1038/eye.2015.203 Authors: M Gemenetzi & A J Lotery
Intraoperative optical coherence tomography: past, present, and future – (Eye Journal AOP)
Intraoperative optical coherence tomography: past, present, and future Eye advance online publication, December 18 2015. doi:10.1038/eye.2015.255 Author: J P Ehlers
Anatomical and functional retinal changes in multiple sclerosis – (Eye Journal AOP)
Anatomical and functional retinal changes in multiple sclerosis Eye advance online publication, December 18 2015. doi:10.1038/eye.2015.256 Authors: G Cennamo, M R Romano, E C Vecchio, C Minervino, C della Guardia, N Velotti, A Carotenuto, S Montella, G Orefice & G Cennamo